Article Versions Notes

Coibion M, Olivier F, Courtois A, Maes N, Jossa V, Jerusalem G. A Randomized Prospective Non-Inferiority Trial of Sentinel Lymph Node Biopsy in Early Breast Cancer: Blue Dye Compared with Indocyanine Green Fluorescence Tracer. Cancers. 2022; 14(4):888. https://doi.org/10.3390/cancers14040888

Coibion, Michel, Fabrice Olivier, Audrey Courtois, Nathalie Maes, Véronique Jossa, and Guy Jerusalem. 2022. "A Randomized Prospective Non-Inferiority Trial of Sentinel Lymph Node Biopsy in Early Breast Cancer: Blue Dye Compared with Indocyanine Green Fluorescence Tracer" Cancers 14, no. 4: 888. https://doi.org/10.3390/cancers14040888

Coibion, M., Olivier, F., Courtois, A., Maes, N., Jossa, V., & Jerusalem, G. (2022). A Randomized Prospective Non-Inferiority Trial of Sentinel Lymph Node Biopsy in Early Breast Cancer: Blue Dye Compared with Indocyanine Green Fluorescence Tracer. Cancers, 14(4), 888. https://doi.org/10.3390/cancers14040888